The aepEX monitor provides a DoH index based on (adult) MLAEP values. The aim of this observational study is to evaluate the performance of the aepEX as a measure of DoH in children.
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
het gaat niet over "aandoeningen" maar over pediatrische validatie van een monitoring systeem tijdens algehele anesthesie
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The ability of the aepEX to distinguish between different levels of
vigilance/DoH in children between 1 and 18 years of age will be evaluated.
Prediction probability (PK) values will be calculated to describe the
relationship between the aepEX and the University of Michigan Sedation Scale
(UMSS).
Secondary outcome
The dose-response relationship between different propofol-, sevoflurane- and
desflurane-concentrations and the aepEX/BIS will be calculated.
PK values will also be calculated for other possible indicators of DoH, such as
BIS, propofol-, sevoflurane- and desflurane-concentrations and hemodynamic
variables
Background summary
Assessment of depth of hypnosis (DoH) during general anaesthesia has become
increasingly popular during the last decade in both adult and paediatric
patients. The currently available monitoring devices all work with internal
algorithms based on adult encephalogram (EEG) data. Since the EEG of a child
significantly differs from that of an adult, the reliability of EEG-derived DoH
devices in children is needs to be specifically addressed.
With respect to the ability to predict reactions to specific external stimuli
mid-latency auditory evoked potentials (MLAEP) appear to be superior to
processed raw-EEG variables. Like the raw-EEG, MLAEP also develop over a period
extending the first decade of life. Thus paediatric evaluation and validation
of DoH-monitoring systems based on adult MLAEP data is mandatory before they
can be introduced into clinical practice. Simultaneous BIS-registration will
enable us to compare the performance of the aepEX to another established DoH
index.
Study objective
The aepEX monitor provides a DoH index based on (adult) MLAEP values. The aim
of this observational study is to evaluate the performance of the aepEX as a
measure of DoH in children.
Study design
Single centre, prospective observational study
aepEX/BIS monitoring is applied to children who undergo elective surgery under
general anaesthesia with propofol, sevoflurane and desflurane. Besides aepEX
monitoring the patients* vigilance / level of hypnotic depth will be assessed
intermittently by means of the UMSS.
All data analyses will be performed off-line after completion of the patient
related part of the study.
The ability of the aepEX* and other indicators (Propofol-, sevoflurane- and
desflurane-concentration, Heart Rate, Blood Pressure, BIS) to describe DoH will
be assessed using Prediction Probability (PK) Analysis. PK analysis has been
established in anaesthesia to compare the performance of indicators of DoH
having different units of measurement.
The effects of different propofol-, sevoflurane-, and desflurane-concentrations
on the aepEX, the BIS, the UMSS and hemodynamic variables will be assessed by
means of general-linear-models analyses.
Study burden and risks
Participants of the study undergo surgical procedures under general
anaesthesia. The common anaesthesia risk-factors are not affected by the study.
The only additional theoretical risk is that of a mild skin irritation caused
by the standard ECG electrodes used for MLAEP registration and the
BIS-electrode. We have been using these electrodes for several years now
without problems.
Nonetheless this issue has been added to the patient information folder as a
possible side effect.
Dr. Molewaterplein 60
3015GJ Rotterdam
NL
Dr. Molewaterplein 60
3015GJ Rotterdam
NL
Listed location countries
Age
Inclusion criteria
- Age between 1 and 18 years
- Scheduled for elective surgery not requiring postoperative ventilatory support and/or sedation
- Parental written informed consent (in patients older than 12 years also written informed consent from the patients
Exclusion criteria
- Known allergy to propofol, remifentanil, or desflurane and sevoflurane
- Planned postoperative admission to the Paediatric Intensive Care Unit, ventilatory support and/or sedation
- Significant hearing difficulties or deafness
- Acute or chronic intake of drugs affecting the EEG
- Inability to obtain written informed consent
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL35976.078.11 |